Atlas Trials

A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China

Clinical trial NCT07316062 · RECRUITING

Trial details

NCT number
NCT07316062
Sponsor
AstraZeneca
Status
RECRUITING
Study type
OBSERVATIONAL
Non-Small-Cell Lung
Start date
2026-04-29
Primary completion
2029-04-30
Enrollment
3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.